Quality of life as a reflection of metabolic indicators in patients undergoing programmed hemodialysis

Metabolic disorders associated with chronic kidney disease (CKD) can lead to a decrease in the quality of life of patients on hemodialysis. The aim of this study is to analyze the correlation between quality of life (QOL) in patients receiving treatment with PHD and clinical and laboratory indicators. Material and methods. 251 patients with stage 5 CKD were included in the study. There were 108 men and 143 women. The mean age was 54.4 ± 9.9 years. All participants completed a specific quality of life questionnaire KDQOL-SF. Results. The interviewed patients reported more concern about symptoms such as weakness, dizziness, and muscle pain (U = 765, p < 0.001), which was correlated with albumin levels (R = 0.5, p < 0.01) and calcium-phosphorus product levels (R = –0.48, p < 0.05). They also expressed concern about the inability to travel or follow a special diet (U = 553, p < 0.005), which correlated with heart rate levels (R = –0.51, P < 0.1) and serum potassium levels (R = –0.6, P < 0.1). Additionally, the burden of CKD correlated with triglycerides (R = 0.36, p = 0,01).Work capacity is associated with age (R = –0.54; p < 0.001), eKT/V (R = 0.47; p < 0.01). Indicators of cognitive function correlate with blood pressure (BP) (R = –0.51, p < 0,001) and pulse pressure (P = –0,55, p < 0,01). Sexual functions are associated with BP (R = –0,64, p < 0,05), calcium levels (R = 0,76, p > 0.80), iron (0,42, p = 0,90), transferrin saturation coefficient (0.5, p = 0.91). Sleep quality correlates with calcium-phosphate production (0.3, p > 0.15). The feeling of social support correlates with magnesium (0,3, P > 0,8), calcium (0.2, P > 0,1). Conclusions. Correlations between quality of life, blood pressure, albumin, and calcium phosphate metabolism, iron, were found.

1. Chuasuwan A., Pooripussarakul S., Thakkinstian A., Ingsathit A., Pattanaprateep O. Comparisons of quality of life between patients underwent peritoneal dialysis and hemodialysis: a systematic review and meta-analysis. Health Qual Life Outcomes. 2020;18(1):191. DOI: 10.1186/s12955-020-01449-2

2. Saran R., Robinson B., Abbott K.C., Agodoa L.Y., Bhave N., Bragg-Gresham J. US renal data system 2017 annual data report: epidemiology of kidney disease in the United States. American Journal of Kidney Diseases. 71.3 (2018):A7.

3. Brown E.A., Zhao J., McCullough K., Fuller D.S., Figueiredo A.E., Bieber B. et al. PDOPPS patient support working group. burden of kidney disease, health-related quality of life, and employment among patients receiving peritoneal dialysis and in-center hemodialysis: findings from the DOPPS Program. Am. J. Kidney Dis. 2021;78(4):489–500.e1. DOI: 10.1053/j.ajkd.2021.02.327

4. Lee H.J., Son Y.J. Prevalence and associated factors of frailty and mortality in patients with end-stage renal disease undergoing hemodialysis: a systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2021;18(7):3471. DOI: 10.3390/ijerph18073471

5. Thurlow J.S., Joshi M., Yan G., Norris K.C., Agodoa L.Y., Yuan C.M., Nee R. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy. Am. J. Nephrol. 2021;52(2):98–107. DOI: 10.1159/000514550

6. Alencar S.B.V., de Lima F.M., Dias L.D.A., Dias V.D.A., Lessa A.C., Bezerra J.M., Apolinário J.F., de Petribu K.C. Depression and quality of life in older adults on hemodialysis. Braz. J. Psychiatry. 2020;42(2):195–200. DOI: 10.1590/1516-4446-2018-0345

7. Fletcher B.R., Damery S., Aiyegbusi O.L., Anderson N., Calvert M., Cockwell P. et al. Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and metaanalysis. PLoS Med. 2022;19(4):e1003954. DOI: 10.1371/journal.pmed.1003954

8. Karava V., Dotis J., Kondou A., Printza N. Malnutrition patterns in children with chronic kidney disease. Life (Basel). 2023;13(3):713. DOI: 10.3390/life13030713. Persaud-Sharma D, Saha S, Trippensee AW. Refeeding Syndrome. 2022 In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. .

9. A Lim K., Hee Lee J. Factors affecting quality of life in patients receiving hemodialysis. Iran J. Public Health. 2022;51(2):355-363. DOI: 10.18502/ijph.v51i2.8688

10. Naseef H.H., Haj Ali N., Arafat A., Khraishi S., AbuKhalil A.D., Al-Shami N. et al. Quality of life of palestinian patients on hemodialysis: cross-sectional observational study. Scientific World Journal. 2023;2023:4898202. DOI: 10.1155/2023/4898202

11. Mondal E., Khan M.M., Hossain M.I., Moshwan M.M., Saha R., Das S.N., Moniruzzaman M. The pattern of lipid profile in patients with chronic kidney disease. Mymensingh Med. J. 2021;30(1):48–55.

12. McAdams-DeMarco M.A., Daubresse M., Bae S., Gross A.L., Carlson M.C., Segev D.L. Dementia, Alzheimer’s disease, and mortality after hemodialysis initiation. Clin. J. Am. Soc. Nephrol. 2018;13(9):1339–1347. DOI: 10.2215/CJN.10150917

13. Pépin M., Ferreira A.C., Arici M., Bachman M., Barbieri M., Bumblyte I.A. et al. CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target). Cognitive disorders in patients with chronic kidney disease: specificities of clinical assessment. Nephrol. Dial. Transplant. 2021;37(2):ii23–ii32. DOI: 10.1093/ndt/gfab262. Erratum in: Nephrol Dial Transplant. Erratum in: Nephrol Dial Transplant. 2022;37(8):1589

14. Yang Y., Da J., Li Q., Long Y., Yuan J., Zha Y. The impact of malnutrition, inflammation on cognitive impairment in hemodialysis patients: a multicenter study. Kidney Blood Press Res. 2022;47(12):711–721. DOI: 10.1159/000527453

15. Nishikawa M., Shimada N., Kanzaki M., Ikegami T., Fukuoka T., Fukushima M., Asano K. The characteristics of patients with hypermagnesemia who underwent emergency hemodialysis. Acute Med. Surg. 2018;5(3):222–229. DOI: 10.1002/ams2.334

16. Sakaguchi Y. The emerging role of magnesium in CKD. Clin. Exp. Nephrol. 2022;26(5):379–384. DOI: 10.1007/s10157-022-02182-4

17. Han Z., Zhou L., Liu R., Feng L. The effect of hemodialysis on serum magnesium concentration in hemodialysis patients. Ann. Palliat. Med. 2020;9(3):1134–1143. DOI: 10.21037/apm-20-992

18. Chou J., Kiebalo T., Jagiello P., Pawlaczyk K. Multifaceted Sexual Dysfunction in Dialyzing Men and Women: Pathophysiology, Diagnostics, and Therapeutics. Life (Basel). 2021;11(4):311. DOI: 10.3390/life11040311

19. Tekkarismaz N., Tunel M., Ozer C. Dialysis modality and sexual dysfunction in male patients. Andrologia. 2020;52(10):e13735. DOI: 10.1111/and.13735

20. Al Naamani Z., Gormley K., Noble H., Santin O., Al Maqbali M. Fatigue, anxiety, depression and sleep quality in patients undergoing haemodialysis. BMC Nephrol. 2021;22(1):157. DOI: 10.1186/s12882-021-02349-3

21. Viggiano D., Wagner C.A., Martino G., Nedergaard M., Zoccali C., Unwin R., Capasso G. Mechanisms of cognitive dysfunction in CKD. Nat. Rev. Nephrol. 2020;16(8):452–469. DOI: 10.1038/s41581-020-0266-9

22. Wang Y., Zhu J., Cao J., Zheng D., Wang L. Remote diagnosis system of uremia complicated with sleep disorder and effectiveness of nursing intervention. Contrast Media Mol. Imaging. 2021;2021:4649139. DOI: 10.1155/2021/4649139